Jean-Marc Bellemin

2020 - Lion Biotechnologies

In 2020, Jean-Marc Bellemin earned a total compensation of $5M as Chief Financial Officer at Lion Biotechnologies.

Compensation breakdown

Bonus$130,000
Option Awards$4,418,700
Salary$450,000
Total$4,998,700

Bellemin received $4.4M in option awards, accounting for 88% of the total pay in 2020.

Bellemin also received $130K in bonus and $450K in salary.

Rankings

In 2020, Jean-Marc Bellemin's compensation ranked 2,214th out of 13,090 executives tracked by ExecPay. In other words, Bellemin earned more than 83.1% of executives.

ClassificationRankingPercentile
All
2,214
out of 13,090
83rd
Division
Manufacturing
849
out of 5,618
85th
Major group
Chemicals And Allied Products
303
out of 2,251
87th
Industry group
Drugs
258
out of 1,951
87th
Industry
Biological Products, Except Diagnostic Substances
73
out of 411
82nd

Pay ratio

Jean-Marc Bellemin's Pay$4,998,700
Median Employee's Pay$445,643
Pay Ratio

11

to 1

In 2020, the annual total compensation of Jean-Marc Bellemin was $4,998,700.

The annual total compensation of the median employee at Lion Biotechnologies was $445,643.

The ratio of Jean-Marc Bellemin's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on April 27, 2021.

Bellemin's colleagues

We found five more compensation records of executives who worked with Jean-Marc Bellemin at Lion Biotechnologies in 2020.

2020

Maria Fardis

Lion Biotechnologies

Chief Executive Officer

2020

Frederick Vogt

Lion Biotechnologies

General Counsel

2020

Friedrich Finckenstein

Lion Biotechnologies

Chief Medical Officer

2020

Michael Swartzburg

Lion Biotechnologies

Former Vice President, Finance and interim Principal Financial Officer and Principal Accounting Officer

2020

Timothy Morris

Lion Biotechnologies

Chief Financial Officer

News

In-depth

You may also like